Clinical Trial Update: Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and preliminary efficacy of Universal PSMA CAR-T cells in patients with refractory metastatic castration-resistant …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Universal PSMA CAR-T

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Metastatic Prostate Cancer, Castration-resistant Prostate Cancer | Phase 1 | Status: RECRUITING